{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:04:47Z","timestamp":1790975087069,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012456","name":"National Social Science Fund of China","doi-asserted-by":"publisher","award":["81900005"],"award-info":[{"award-number":["81900005"]}],"id":[{"id":"10.13039\/501100012456","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project for Prevention and Control of Emerging, Reemerging and Major Infectious Diseases","award":["2025ZD01907905"],"award-info":[{"award-number":["2025ZD01907905"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Children with primary immunodeficiency (PID) may develop severe infections after BCG vaccination. There is limited information on the long-term prognosis and management of these BCG-induced diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were gathered from a cohort study on BCG-induced diseases at the Shanghai Public Health Clinical Center, spanning from January 2007 to August 2022. The study enrolled patients with confirmed PIDs, and information was obtained via personal interviews with patients or their guardians, as well as from their medical records. This allowed us to gather clinical and genetic details, treatment history, and the outcomes of their PIDs. We evaluated antimycobacterial outcomes and analyzed the impact of HSCT and IFN-\u03b3 therapy on the risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 422 patients with BCG-induced diseases, 109 patients with confirmed PID were included in the analysis. Of these, 88.1% had developed distant or disseminated BCG infection, and the median duration of illness documented in the study was 57 months (IQR 31\u201379). The three most common PIDs in this cohort were MSMD (47\/109, 43.1%), CGD (28\/109, 25.7%), and CID (19\/109 or 17.4%). The estimated five-year and ten-year survival rates were 80.3% (95%CI, 72.1%-88.5%) and 69.3% (95%CI, 56.8%-81.8%). Patients who received hematopoietic stem cell transplantation therapy (HSCT) had a significantly higher success rate with antimycobacterial treatment (75.8% vs. 0%). The survival benefit of HSCT varies across immunodeficiency types but is clearly beneficial for CID (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). IFN-\u03b3 therapy presented no significant effect on the survival of CGD and MSMD. The initial STRONGkids nutritional score (HR\u2009=\u20092.27 per point, 95%CI 1.65\u20133.13) and gender (HR for male\u2009=\u20094.89, CI 1.36\u201317.57) are significant predictors of survival. Mutations in 6 genes (\n                      <jats:italic>IL12RB1<\/jats:italic>\n                      ,\n                      <jats:italic>CYBB<\/jats:italic>\n                      ,\n                      <jats:italic>IFNGR1<\/jats:italic>\n                      ,\n                      <jats:italic>IL2RG<\/jats:italic>\n                      ,\n                      <jats:italic>STAT1<\/jats:italic>\n                      ,\n                      <jats:italic>and RAG1<\/jats:italic>\n                      ) account for 66% of BCG-associated immunodeficiency mutations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PID complicated by BCG infection may cause persistent and severe conditions. Patients with severe nutritional risk in the early stages of infection have a higher risk of death and should prioritize HSCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-026-01996-1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:16:17Z","timestamp":1772136977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Immunodeficiency Diseases with BCG-Induced Diseases: A 15-Year Longitudinal Cohort Study"],"prefix":"10.1007","volume":"46","author":[{"given":"Lu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"1","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, Mandalakas AM. 100 years of Mycobacterium Bovis Bacille Calmette-Gu\u00e9rin. Lancet Infect Dis. 2022;22(1):e2\u201312.","journal-title":"Lancet Infect Dis"},{"key":"1996_CR2","unstructured":"World Health Organization. The immunological basis for immunization series: module 5: tuberculosis, update 2021. Geneva World Health Organization; 2021."},{"issue":"3","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012.","journal-title":"PLoS Med"},{"issue":"1","key":"1996_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12272","volume":"264","author":"S Boisson-Dupuis","year":"2015","unstructured":"Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El Azbaoui S, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264(1):103\u201320.","journal-title":"Immunol Rev"},{"issue":"5","key":"1996_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3201\/eid1305.060865","volume":"13","author":"EA Bernatowska","year":"2007","unstructured":"Bernatowska EA, Wolska-Kusnierz B, Pac M, Kurenko-Deptuch M, Zwolska Z, Casanova JL, et al. Disseminated Bacillus Calmette-Gu\u00e9rin infection and immunodeficiency. Emerg Infect Dis. 2007;13(5):799\u2013801.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10875-022-01422-2","volume":"43","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Ying W, Wang W, Hou J, Liu L, Sun B, et al. Clinical and genetic characteristics of BCG disease in Chinese children: a retrospective study. J Clin Immunol. 2023;43(4):756\u201368.","journal-title":"J Clin Immunol"},{"key":"1996_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijid.2020.05.117","volume":"97","author":"RYL Ong","year":"2020","unstructured":"Ong RYL, Chan SB, Chew SJ, Liew WK, Thoon KC, Chong CY, et al. Disseminated Bacillus-Calmette-Gu\u00e9rin infections and primary immunodeficiency disorders in Singapore: a single center 15-year retrospective review. Int J Infect Dis. 2020;97:117\u201325.","journal-title":"Int J Infect Dis"},{"key":"1996_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2019.00073","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zhou X, Ling Y, Jiang N, Ai J, Wu J, et al. Genetic and clinical profiles of disseminated Bacillus Calmette-Gu\u00e9rin disease and chronic granulomatous disease in China. Front Immunol. 2019;10:73.","journal-title":"Front Immunol"},{"issue":"3","key":"1996_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","volume":"41","author":"SG Tangye","year":"2021","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. The Ever-Increasing array of novel inborn errors of immunity: an interim update by the IUIS committee. J Clin Immunol. 2021;41(3):666\u201379.","journal-title":"J Clin Immunol"},{"key":"1996_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.coi.2021.07.001","volume":"72","author":"S Boisson-Dupuis","year":"2021","unstructured":"Boisson-Dupuis S, Bustamante J. Mycobacterial diseases in patients with inborn errors of immunity. Curr Opin Immunol. 2021;72:262\u201371.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","volume":"8","author":"S Fekrvand","year":"2020","unstructured":"Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. A. Primary immunodeficiency diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-Vaccine-Derived complications: A systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371\u201386.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"1996_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ni.1992","volume":"12","author":"J Bustamante","year":"2011","unstructured":"Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213\u201321.","journal-title":"Nat Immunol"},{"issue":"3","key":"1996_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a National registry of 368 patients. Med (Baltim). 2000;79(3):155\u201369.","journal-title":"Med (Baltim)"},{"issue":"4","key":"1996_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update. Immunol Cell Biol. 2019;97(4):360\u20137.","journal-title":"Immunol Cell Biol"},{"key":"1996_CR15","doi-asserted-by":"publisher","first-page":"926781","DOI":"10.3389\/fimmu.2022.926781","volume":"13","author":"L Xia","year":"2022","unstructured":"Xia L, Liu XH, Yuan Y, Lowrie DB, Fan XY, Li T, et al. An updated review on MSMD research globally and A literature review on the molecular Findings, clinical Manifestations, and treatment approaches in China. Front Immunol. 2022;13:926781.","journal-title":"Front Immunol"},{"issue":"5","key":"1996_CR16","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186\u2013205. .e1-78.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","unstructured":"International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324(8):509\u201316.","journal-title":"N Engl J Med"},{"issue":"5","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39(5):692\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6\u20137","key":"1996_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","volume":"139","author":"J Bustamante","year":"2020","unstructured":"Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet. 2020;139(6\u20137):993\u20131000.","journal-title":"Hum Genet"},{"issue":"6","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1172\/JCI135460","volume":"130","author":"G Kerner","year":"2020","unstructured":"Kerner G, Rosain J, Gu\u00e9rin A, Al-Khabaz A, Oleaga-Quintas C, Rapaport F, Massaad MJ, et al. Inherited human IFN-\u03b3 deficiency underlies mycobacterial disease. J Clin Invest. 2020;130(6):3158\u201371.","journal-title":"J Clin Invest"},{"issue":"4","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1086\/499953","volume":"42","author":"AC Hesseling","year":"2006","unstructured":"Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette-Gu\u00e9rin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006;42(4):548\u201358.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1996_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clnu.2009.07.006","volume":"29","author":"JM Hulst","year":"2010","unstructured":"Hulst JM, Zwart H, Hop WC, Joosten KF. Dutch National survey to test the STRONGkids nutritional risk screening tool in hospitalized children. Clin Nutr. 2010;29(1):106\u201311.","journal-title":"Clin Nutr"},{"issue":"9","key":"1996_CR23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy675","volume":"219","author":"P Sinha","year":"2019","unstructured":"Sinha P, Davis J, Saag L, Wanke C, Salgame P, Mesick J, et al. Undernutrition and tuberculosis: public health implications. J Infect Dis. 2019;219(9):1356\u201363.","journal-title":"J Infect Dis"},{"key":"1996_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00463-0","author":"T Burki","year":"2023","unstructured":"Burki T. WHO paediatric tuberculosis roadmap. The Lancet. Respiratory medicine, S2213-2600(23)00463-0. 5 Dec. 2023. https:\/\/doi.org\/10.1016\/S2213-2600(23)00463-0.","journal-title":"5 Dec"},{"key":"1996_CR25","doi-asserted-by":"publisher","first-page":"805766","DOI":"10.3389\/fimmu.2021.805766","volume":"12","author":"K Mitsui-Sekinaka","year":"2022","unstructured":"Mitsui-Sekinaka K, Sekinaka Y, Endo A, Imai K, Nonoyama S. The primary immunodeficiency database in Japan. Front Immunol. 2022;12:805766. https:\/\/doi.org\/10.3389\/fimmu.2021.805766.","journal-title":"Front Immunol"},{"issue":"suppl2","key":"1996_CR26","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/jpids\/piy114","volume":"7","author":"AF Freeman","year":"2018","unstructured":"Freeman AF. Hematopoietic stem cell transplantation in primary immunodeficiencies beyond severe combined immunodeficiency. J Pediatr Infect Dis Soc. 2018;7(suppl2):S79\u201382.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"5","key":"1996_CR27","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jaci.2013.05.031","volume":"132","author":"T Cole","year":"2013","unstructured":"Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;132(5):1150\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1996_CR28","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s10875-021-01116-1","volume":"41","author":"N Radwan","year":"2021","unstructured":"Radwan N, Nademi Z, Lum SH, Flood T, Abinun M, Owens S, et al. Outcome of hematopoietic stem cell transplantation in patients with Mendelian susceptibility to mycobacterial diseases. J Clin Immunol. 2021;41(8):1774\u201380.","journal-title":"J Clin Immunol"},{"key":"1996_CR29","doi-asserted-by":"publisher","first-page":"654406","DOI":"10.3389\/fimmu.2021.654406","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Chen X, Gao G, Xing S, Zhou L, Tang X, et al. Clinical relevance of Gain- and Loss-of-Function germline mutations in STAT1: A systematic review. Front Immunol. 2021;12:654406.","journal-title":"Front Immunol"},{"issue":"6","key":"1996_CR30","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/ajcn\/nqaa142","volume":"112","author":"NE Lara-Pompa","year":"2020","unstructured":"Lara-Pompa NE, Hill S, Williams J, Macdonald S, Fawbert K, Valente J, et al. Use of standardized body composition measurements and malnutrition screening tools to detect malnutrition risk and predict clinical outcomes in children with chronic conditions. Am J Clin Nutr. 2020;112(6):1456\u201367.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1996_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ncp.10589","volume":"36","author":"CAD Santos","year":"2021","unstructured":"Santos CAD, Rosa COB, Franceschini SDCC, Firmino HH, Ribeiro AQ. Nutrition risk assessed by STRONGkids predicts longer hospital stay in a pediatric cohort: A survival analysis. Nutr Clin Pract. 2021;36(1):233\u201340.","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"1996_CR32","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1183\/09031936.00118414","volume":"45","author":"H Salvator","year":"2015","unstructured":"Salvator H, Mahlaoui N, Catherinot E, Rivaud E, Pilmis B, Borie R, et al. Pulmonary manifestations in adult patients with chronic granulomatous disease. Eur Respir J. 2015;45(6):1613\u201323.","journal-title":"Eur Respir J"},{"issue":"8","key":"1996_CR33","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176\u201383.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1996_CR34","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","volume":"148","author":"J Thalhammer","year":"2021","unstructured":"Thalhammer J, Kindle G, Nieters A, Rusch S, Sepp\u00e4nen MRJ, Fischer A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332\u2013e13415.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1996_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.aller.2020.04.004","volume":"48","author":"M Sohani","year":"2020","unstructured":"Sohani M, Habibi S, Delavari S, Shahkarami S, Yazdani R, Shirmast P et al. Evaluation of patients with primary immunodeficiency associated with Bacille Calmette-Guerin (BCG)-vaccine-derived complications. Allergol Immunopathol (Madr). 2020; 48(6):729\u201337.","journal-title":"Allergol Immunopathol (Madr)"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-01996-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-01996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-01996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:58:12Z","timestamp":1781636292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-01996-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-01996-1","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai Public Health Clinical Center (2021S06002). The study obtained a waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}